Latest filing published 11 Jun 2026 for Axsome Therapeutics, Inc., €62k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Jeffs Roger on record concern Axsome Therapeutics, Inc. We count 2 filings; the first trade dates from 10 June 2026 and the latest from 11 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 11 June 2026 came the latest disclosure, a transaction for €62k in Axsome Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations